Clinical Oncology Business PerformanceThe company's clinical oncology business showed strong performance with revenue increasing by 35% and volumes growing by 23%.
Data & Services Revenue PerformanceData & Services revenue grew by 45%, mainly driven by the Insights business which saw a 66% year-over-year increase.
Path To ProfitabilityTempus is now expecting to reach EBITDA profitability a year ahead of prior expectations, which is viewed positively given the challenges digital health companies face in achieving profitability.